ARDX Nilai Total Aset Perusahaan Ardelyx Inc

Ardelyx, Inc. (ARDX) is a niche player in nephrology whose strategy relies on exclusive patents and the ability to independently determine therapy costs for insurers. This chart shows the market value of total assets reaching 521.54, confirming the company's financial foundation. High demand for Xphozah is driven by its unique phosphorus-blocking mechanism, making the drug indispensable. A rapid increase in prescriptions currently serves as the primary driver of revenue growth.

ARDX (Ardelyx, Inc.) riwayat Total Aset Perusahaan saka 04.07.2022 nganti 29.10.2026

Rincian analitis lan laporan data perusahaan Ardelyx Pharma (ARDX)

- kuotasi lan prakiraan analis:

Kurs saham ardelyx.com|ARDX - Bagan rega target

- data kapitalisasi pasar:

Biji pasar Ardelyx Corp|ARDX - Nilai Perusahaan

- statistik nilai buku emiten:

Nilai Akuntansi Saham Ardelyx|ARDX - Kapitalisasi Buku|Rasio Kapitalisasi Pasar marang Nilai Buku ardelyx.com|ARDX - Aset Agregat Perusahaan

- indikator beban utang lan likuiditas:

Rasio Kabeh Utang marang Dana Pribadi Ardelyx, Inc.|ARDX - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas Ardelyx Corp|ARDX - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Ardelyx Corp|ARDX - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Ardelyx

Pambiji fundamental:Ardelyx, Inc.

Total assets represent the aggregate of company resources, calculated reverse-engineered via ROA to eliminate quarterly reporting time lags and assess operational liquidity. By analyzing the trajectory of total balance sheet assets on GURU.Markets, an investor can evaluate the ability of Ardelyx, Inc. (ARDX) to scale the expansion of its unique nephrology-focused drugs into the dialysis market, balancing capitalization growth against the risks of frozen funds.

Pesaing wigati